CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
CEL SCI CORP
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.65−0.14 (-7.82%)
Close on Oct 19, 2026
- Market cap
- $19.99M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Aug 14, 2025(first seen in filings) | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |
| May 20, 2025 | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |
| Aug 9, 2017(first seen in filings) | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Jun 15, 2017 | 1-for-25 reverse | Earlier per-share figures multiplied by 25 |
| Dec 27, 2013(first seen in filings) | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Sep 25, 2013 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| May 1, 1995 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |